series-c-plus
Stage
2017
Founded
4
Investors
About
Kinnate Biopharma develops precision kinase inhibitors to treat genetically defined cancers and rare diseases.
Explore Kinnate-4's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.